NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,897 | +3.5% | 11,580 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,661 | -45.5% | 11,580 | -33.3% | 0.00% | -50.0% |
| Q1 2023 | $12,211 | -68.9% | 17,370 | 0.0% | 0.00% | -71.4% |
| Q4 2022 | $39,256 | -29.9% | 17,370 | 0.0% | 0.01% | -41.7% |
| Q3 2022 | $56,000 | -15.2% | 17,370 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $66,000 | -29.8% | 17,370 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $94,000 | -60.0% | 17,370 | 0.0% | 0.02% | -61.0% |
| Q4 2021 | $235,000 | -24.7% | 17,370 | 0.0% | 0.04% | -18.0% |
| Q3 2021 | $312,000 | +4.7% | 17,370 | 0.0% | 0.05% | +6.4% |
| Q2 2021 | $298,000 | -33.3% | 17,370 | -25.0% | 0.05% | -39.7% |
| Q1 2021 | $447,000 | +13.5% | 23,160 | 0.0% | 0.08% | +27.9% |
| Q4 2020 | $394,000 | +2.6% | 23,160 | 0.0% | 0.06% | -17.6% |
| Q3 2020 | $384,000 | – | 23,160 | +115700.0% | 0.07% | – |
| Q2 2020 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |